Lydall Inc. (LDL) Drops 7.14% on January 13

Equities Staff |

Lydall Inc. (LDL) was one of the Russell 2000's biggest losers for Wednesday January 13 as the stock slid 7.14% to $28.49, a loss of $-2.19 per share. Starting at an opening price of $30.66 a share, the stock traded between $28.36 and $30.78 over the course of the trading day. Volume was 44,074 shares over 493 trades, against an average daily volume of 87,833 shares and a total float of 17.04 million.

The losses send Lydall Inc. down to a market cap of $485.52 million. In the last year, Lydall Inc. has traded between $38.86 and $25.28, and its 50-day SMA is currently $34.70 and 200-day SMA is $30.64.

The stock has a P/E Ratio of 11.2.

Lydall Inc, through its subsidiaries designs and manufactures specialty engineered filtration media, industrial thermal insulating solutions, automotive thermal and acoustical barriers, medical filtration media and devices.

Lydall Inc. is based out of Manchester, CT and has some 2,100 employees. Its CEO is Dale G. Barnhart.

For a complete fundamental analysis analysis of Lydall Inc., check out’s Stock Valuation Analysis report for LDL. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Relevium Technologies Inc.

Relevium Technologies Inc is engaged in the acquisition of products, technologies and businesses relating to musculoskeletal function, specifically Pain Relief, Injury Recovery and Active Performance.

Private Markets


The spark hit Jamie when he saw co-workers competing to lose weight. Instead of pizzas and subs, they were eating salads and jogging along the river. Some were sneakily leaving…


Cloudera offers enterprises a new data platform built on the Apache Hadoop open-source software package. Hadoop is a data-management platform that can consolidate data in a single repository for comprehensive…